XML 21 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2014
Building [Member]      
Non-cash items included in net income      
Gain on disposition of building $ (343,000)
Net income 9,482,000 5,151,000 930,000
Depreciation and amortization 6,677,000 6,331,000 6,226,000
Goodwill and intangible asset impairment [1] 805,000
Deferred income taxes (1,117,000) (226,000) 856,000
Deferred compensation plan 151,000 (761,000) 99,000
Stock based compensation expense 2,903,000 1,239,000 1,005,000
Issuance of common shares as compensation 248,000 191,000 193,000
Gain on disposition of building (343,000)
Loss on disposition of fixed assets (1,000) 9,000 36,000
Loss on sale of subsidiary 565,000
Allowance for doubtful accounts 55,000 220,000 6,000
Inventory obsolescence reserve 1,726,000 1,493,000 1,464,000
Change in certain assets and liabilities      
Accounts receivable (3,369,000) (1,631,000) 3,232,000
Inventories (2,784,000) 1,000 (4,779,000)
Refundable income taxes 99,000 1,815,000 (538,000)
Accounts payable (1,130,000) 910,000 1,229,000
Accrued expenses and other 5,116,000 6,115,000 269,000
Customer prepayments (271,000) (149,000) 526,000
Net cash flows provided by operating activities 17,785,000 20,930,000 11,559,000
Cash Flows From Investing Activities      
Purchases of property, plant, and equipment (10,211,000) (4,754,000) (5,245,000)
Proceeds from sale of subsidiary, net of cash sold 1,494,000
Proceeds from sale of fixed assets 68,000 1,006,000 255,000
Net cash flows (used in) investing activities (10,143,000) (2,254,000) (4,990,000)
Cash Flows From Financing Activities      
Cash dividends paid (4,214,000) (2,900,000) (5,780,000)
Purchase of treasury shares (363,000) (205,000) (188,000)
Issuance of treasury shares 340,000 975,000 64,000
Exercise of stock options 4,021,000 850,000 399,000
Net cash flows (used in) financing activities (216,000) (1,280,000) (5,505,000)
Increase in cash and cash equivalents 7,426,000 17,396,000 1,064,000
Cash and cash equivalents at beginning of year 26,409,000 9,013,000 7,949,000
Cash and cash equivalents at end of year $ 33,835,000 $ 26,409,000 $ 9,013,000
[1] The Company recorded a significant impairment of goodwill and/or intangible assets in fiscal 2014 and 2013, and a minor impairment in fiscal 2012. See Note 6.